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Abstract 
Intraductal papillary neoplasm of the bile duct (IPNB) represents biliary papillary tumors 
mainly growing and is considered to be of relatively low-grade malignancy. Here we 
report a case of IPNB in whom the poorly differentiated component deeply infiltrated the 
bile duct wall. A 77-year-old male had an invasive carcinoma of the bile duct 3 cm in size. 
He underwent right hemihepatectomy with combined resection of the extrahepatic bile 
duct. Papillary growing tumor was observed in the common bile duct and the right 
posterior Glisson’s pedicle was invaded. Histologic finding showed papillary 
adenocarcinoma in the surface layer superficially extending to the epithelium of the 
surrounding bile duct. In the subserosal layer, the tumor represented poorly 
differentiated adenocarcinoma. The tumor was diagnosed as invasive bile duct 
carcinoma arising from IPNB. 
 
Introduction 
Intraluminal papillary tumors of extra- or intrahepatic bile ducts generally show high- 
or low-grade dysplasia or are well-differentiated adenocarcinomas [1]. These types of 
tumors are not infrequently associated with superficial spread of carcinoma cells along 
the biliary mucosa without invasiveness [2]. Approximately 10% of hilar bile duct  
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carcinomas are of the papillary type while approximately 15% of intrahepatic 
cholangiocarcinomas are of the intraductal growth type [3]. Biliary papillomatosis or 
papilloma are also sometimes included in this category of biliary tumors [4]. This type of 
biliary papillary tumor shows less invasiveness and more favorable outcome compared 
with other types of intrahepatic cholangiocarcinomas and not infrequently presents as 
multifocal papillary epithelial lesions in the bile duct with or without mucin production 
[5]. Chen et al. [6] and Nakanuma et al. [7] surveyed such cases in Taiwan and also in 
Japan, and they proposed the collective term of intraductal papillary neoplasm of the bile 
duct (IPNB) for such biliary papillary tumors. Interestingly, the clinicopathological 
features of IPNB resemble those of intraductal papillary mucin-producing neoplasia 
(IPMN) of the pancreas [8–10]. Although IPNB is considered to be of relatively low-grade 
malignancy [8, 11], the clinical spectrum and characteristics of IPNB itself including 
postsurgical prognosis have not been fully evaluated. In this report, we present a case of 
IPNB with subserosal invasion by the component of poorly differentiated carcinoma. 
Case Report 
Here we describe a case of IPNB in a 77-year-old male with liver dysfunction and diabetes. The 
patient had no history of liver diseases such as viral hepatitis or alcoholic liver disease. Increased 
alkaline phosphatase level was found during the follow-up of diabetes. When examining abdominal 
images, biliary tumor was observed and, therefore, the patient was referred to our institute. Laboratory 
data showed mild obstructive jaundice as 1.5 mg/dl of total bilirubin, 49 IU/l of alanine 
aminotransferase, and 663 IU/l of alkaline phosphatase. Indocyanine green retention rate at 15 min was 
increased with 27.4% (normal range <10%) and the liver uptake ratio by 
99mTc-galactosyl human serum 
albumin liver scintigraphy was decreased with 0.88 (normal range >0.9), which indicated injured liver 
function by biliary obstruction. Serum level of CA19-9 was highly increased with 124 U/ml (normal 
range <37 U/ml). Computed tomography (CT) showed a tumor of the bile duct 3 cm in size extending 
to the hepatic hilum (fig. 1). The bile duct in the right lateral sector was obstructed by tumor invasion 
and the portal branch in the same sector was stenotic. We performed right hepatectomy and combined 
resection of the common hepatic and bile duct and a regional lymphadenectomy was added. Papillary 
growing soft tumor was observed in the upper and middle bile duct, and the right lateral Glisson’s 
pedicle and the cystic duct were obstructed by the tumor invasion (fig. 2). The tumor was 3.1 × 1.6 cm 
in size. The hepatic duct in the right paramedian sector and the left hepatic duct were remarkably 
dilated without obstruction and the intraductal lumen showed normal appearance in the resected 
specimen. Histologic finding showed remarkably papillary adenocarcinoma in the layer of the 
intraluminal side (fig. 3a), which was superficially extending (2 cm from the main tumor) to the 
epithelium of the intrahepatic duct. In the subserosal layer, the tumor transformed to poorly 
differentiated adenocarcinoma which obstructed the bile ducts in the right lateral sector (fig. 3b). Slight 
perineural, lymphatic and venous infiltrations were observed; however, there was no lymph node 
metastasis. Immunohistochemical analysis showed positive expression of MUC1, MUC4 and 
MUC5AC,negative expression of MUC2 and p53 overexpression. By pathologic consultation, the tumor 
was diagnosed as an invasive bile duct carcinoma arising from IPNB, pacreatobiliary type. 
Discussion 
IPNB may evolve through a common pathological process and shares 
clinicopathological features with pancreatic cystic neoplasms such as IPMN [7]. Helical 
CT and MR imaging can identify dilation and cystic changes in biliary and pancreatic 
ducts in asymptomatic patients [9, 12],
 enabling diagnosis of malignancy at an earlier 
stage and providing reliable patient follow-up. Since the mechanism of carcinogenesis of 
pancreatic cystic neoplasms has been clarified by advances in histological and molecular 
diagnostic techniques, it is now clear that intraepithelial pancreatic neoplasia is the 
microscopic precursor lesion of pancreatic carcinoma, and IPMN or mucinous cystic 
neoplasm are macroscopic precursor lesions [9]. The diagnostic algorithm for pancreatic  
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cystic tumors is designed to distinguish benign from malignant lesions [9, 13]. In bile duct 
carcinomas, on the other hand, intraepithelial biliary neoplasia or IPNB are thought to be 
similar precursor lesions, and the molecular characteristics of carcinogenesis have been 
clarified as well [14, 15]. IPNB seems to be a counterpart of IPMN [7]. However, in our 
experience, most IPNB contained carcinomatous lesions, even the small cystic lesions, 
and mucin production was observed in half of the cases (unpublished data), which was 
different from IPMN. Since the similarities and differences between IPNB and IPMN 
have not been fully clarified yet, the diagnostic or treatment algorithm for IPNB remains 
to be established at this stage. When IPNB is detected, most cases should be scheduled for 
surgical resection based on their malignant potential. 
We have experienced 7 patients of IPNB including the present case [16]; 4 presented 
abdominal pain or discomfort due to biliary obstruction. However, another 3 patients had 
onset of liver dysfunction. There has been an increase in the number of reported cases of 
biliary neoplasms of the hepatobiliary system characterized by marked dilatation of the 
bile ducts or cystic biliary lesions with or without mucin secretion [17]. The number of 
patients who undergo surgical treatment for such lesions has also increased due to 
diagnostic and surgical improvements along with development of imaging modalities 
[18]. Advanced imaging modality can identify dilation and cystic changes in the biliary 
duct at an early stage in such cases. Yeh et al. reported the reliable classification of 
cholangiographic types according to the histopathological types of IPNB [8]. According 
to this imaging classification, the cholangiographic pattern of the present case was 
type IIIA (intrahepatic polypoid or cystic neoplasia with operable concomitant 
malignancy), in which the prevalence of microinvasive adenocarcinoma and papillary 
adenocarcinoma with stromal invasion wase dominant by Yeh’s classification [8]. The 
present case showed a papillary adenocarcinoma with stromal invasion. Therefore, their 
morphological classification using an image diagnostic tool may be reliable to identify 
malignancy of IPNB. The onset of finding in the present case was elevated alkaline 
phosphatase level, which might be reliable to find development of biliary carcinoma [19]. 
The previous report recommended hemihepatectomy or extended hemihepatectomy 
for cases with extending tumor or diffusely dilated bile ducts [20]. In the present case, we 
also selected right hepatectomy for complete curable resection because the tumor seemed 
to extend to the confluent of hepatic duct in the right paramedian sector by CT and 
superficial spreading of the tumor along the biliary epithelium is also a characteristic 
feature of IPNB [1]. In the present case, 2 cm of superficial extension along the epithelium 
to the hepatic duct was observed as expected. It is important to decide on major hepatic 
resection in such cases because of diffuse dilatation of the bile duct extending in a 
segment or lobe and multifocal carcinogenesis [21]. The present case showed stromal 
invasion to the subserosal layer. Yeh et al. reported that 59 of 124 IPNB patients had 
invasive carcinoma [8]. Papillary growing biliary carcinomas might show lower potential 
of malignancy [8]. However, in the present case, the infiltrative portion showed poorly 
differentiated adenocarcinoma and, therefore, it is necessary to consider the malignant 
potential even in IPNB with papillary growth. Since similarity between IPMN and IPNB 
has been considered [7] and prognosis of patients with invasive IPMN is very poor, 
similar to those with pancreatic ductal adenocarcinoma [22], patients with invasive IPNB 
should be carefully monitored and considered to have similar prognosis to those with 
cholangiocellular carcinoma. Zen et al. examined mucinous expression of IPNB [14]. The 
expression of MUC1, MUC2, or MUC5A might correlate with malignant transformation 
from IPNB to invasive or mucinous carcinoma of the bile duct. In our case, the expression 
of MUC2 and p53 was negative, and this finding might be according to the previous 
report [23, 24]. Further studies of cellular characteristics such as protein expression or  
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genetic alterations will be necessary to clarify the pathogenesis of IPNB. IPNB or 
intraductal papillary growth type of intrahepatic cholangiocarcinoma is a good indication 
for surgical resection, and complete resection is associated with better prognosis 
compared with other cholangiocarcinomas [25]. In the present case, lymph node 
metastasis was not observed despite deep invasion with the microscopic infiltration of 
cancer cells in the surrounding tissues. The recent report by Yeh et al. revealed poor 
prognosis in patients with lymph node metastasis (the 5-year survival rate was 14%) [8]. 
Furthermore, the negative surgical margin could be obtained by the extended hepatic 
resection. Good prognosis after operation could be expected by these reasons in the 
present case. To accomplish good prognosis after treatment for IPNB, diagnosis at the 
earliest stage followed by curative resection is necessary. 
In conclusion, we report the clinicopathological findings in a case of IPNB with 
stromal invasion who underwent surgical resection. The malignant potential of IPNB is 
usually lower than that of other bile duct carcinomas; however, it is noted that invasive 
transformation might sometimes occur even in IPNB. Surgical complete resection is a 
better therapeutic choice for IPNB to obtain the good prognosis. 
 
 
 
 
 
Fig. 1. a CT showed a tumor (arrow) in the common bile duct extending to the hepatic hilum. b The 
bile duct in the right lateral sector was obstructed by the tumor and this lesion became atrophic. 
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Fig. 2. A papillary growing soft tumor was observed in the lumen of bile duct, and the right lateral 
Glisson’s pedicle and the cystic duct were obstructed by the tumor invasion. 
 
 
 
Fig. 3. a The papillary adenocarcinoma in the layer of the intraluminal side was identified as IPNB, 
which was superficially extending to the epithelium of the intrahepatic duct. b In the subserosal layer, 
the tumor was changed to poorly differentiated adenocarcinoma, which obstructed the bile ducts in the 
right lateral sector. 
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